This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanano, R.
Right arrow Articles by Kaufmann, S. H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanano, R.
Right arrow Articles by Kaufmann, S. H. E.

 Previous Article  |  Next Article 

Infect. Immun., Jan 1998, 305-314, Vol 66, No. 1
Copyright © 1998, American Society for Microbiology

Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii

R Hanano, K Reifenberg and SH Kaufmann
Department of Immunology, University of Ulm, Germany.

CD4+ T cells are pivotal for elimination of Pneumocystis carinii from infected lungs, and alveolar macrophages are considered the main effector cells clearing the infected host of P. carinii organisms. To investigate this issue, several mutant mouse strains were used in a previously established experimental setup which facilitates natural acquisition of disease through inhalation of airborne fungal organisms. Mutant mice deficient in major histocompatibility complex class II molecules (A beta(-/-)), T-cell receptor alphabeta cells (TCR beta(-/- )), or all mature T and B lymphocytes (RAG-1(-/-)) were naturally susceptible to P. carinii, whereas mouse mutants lacking the gamma interferon (IFN-gamma) receptor (IFN-gamma-R(-/-)) or tumor necrosis factor alpha (TNF-alpha) type I receptor (p55) (TNF-alpha-RI(-/-)) resisted disease acquisition. Analysis of pulmonary cytokine patterns and free radical expression revealed the presence of superoxide, nitric oxide, and interleukin-1 (IL-1) mRNA and elevated levels of IFN-gamma, TNF-alpha, and IL-12 in diseased TCR beta(-/-) and RAG-1(-/-) mice. Pulmonary macrophages of all diseased mouse mutants expressed scavenger and mannose receptors. Morbid A beta(-/-) mutants displayed significant NO levels and IL-1 mRNA only, whereas heterozygous controls did not exhibit any signs of disease. Interestingly, neither IFN-gamma nor TNF- alpha appeared to be essential for resisting natural infection with P. carinii, nor were these cytokines sufficient for mediating resistance during established disease in the absence of CD4+ T lymphocytes. Taken together, the results indicated that an activated phagocyte system, as evidenced by cytokine and NO secretion, in diseased mutants was apparently operative but did not suffice for parasite clearance in the absence of CD4+ TCR alphabeta cells. Therefore, additional pathways, possibly involving interactions of inflammatory cytokines with CD4+ T lymphocytes, must contribute to successful resistance against P. carinii.


This article has been cited by other articles:

  • Rudner, X. L., Happel, K. I., Young, E. A., Shellito, J. E. (2007). Interleukin-23 (IL-23)-IL-17 Cytokine Axis in Murine Pneumocystis carinii Infection. Infect. Immun. 75: 3055-3061 [Abstract] [Full Text]  
  • Atzori, C., Clerici, M., Trabattoni, D., Fantoni, G., Valerio, A., Tronconi, E., Cargnel, A. (2003). Assessment of immune reconstitution to Pneumocystis carinii in HIV-1 patients under different highly active antiretroviral therapy regimens. J Antimicrob Chemother 52: 276-281 [Abstract] [Full Text]  
  • Lund, F. E., Schuer, K., Hollifield, M., Randall, T. D., Garvy, B. A. (2003). Clearance of Pneumocystis carinii in Mice Is Dependent on B Cells But Not on P. carinii-Specific Antibody. J. Immunol. 171: 1423-1430 [Abstract] [Full Text]  
  • Qureshi, M. H., Harmsen, A. G., Garvy, B. A. (2003). IL-10 Modulates Host Responses and Lung Damage Induced by Pneumocystis carinii Infection. J. Immunol. 170: 1002-1009 [Abstract] [Full Text]  
  • Tang, X., Lasbury, M. E., Davidson, D. D., Bartlett, M. S., Smith, J. W., Lee, C.-H. (2000). Down-Regulation of GATA-2 Transcription during Pneumocystis carinii Infection. Infect. Immun. 68: 4720-4724 [Abstract] [Full Text]  
  • Florido, M., Goncalves, A. S., Silva, R. A., Ehlers, S., Cooper, A. M., Appelberg, R. (1999). Resistance of Virulent Mycobacterium avium to Gamma Interferon-Mediated Antimicrobial Activity Suggests Additional Signals for Induction of Mycobacteriostasis. Infect. Immun. 67: 3610-3618 [Abstract] [Full Text]  
  • Walzer, P. D. (1999). Immunological Features of Pneumocystis carinii Infection in Humans. CVI 6: 149-155 [Full Text]  
  • Downing, J. F., Kachel, D. L., Pasula, R., Martin, W. J. II (1999). Gamma Interferon Stimulates Rat Alveolar Macrophages To Kill Pneumocystis carinii by L-Arginine- and Tumor Necrosis Factor-Dependent Mechanisms. Infect. Immun. 67: 1347-1352 [Abstract] [Full Text]  
  • Kolls, J. K., Habetz, S., Shean, M. K., Vazquez, C., Brown, J. A., Lei, D., Schwarzenberger, P., Ye, P., Nelson, S., Summer, W. R., Shellito, J. E. (1999). IFN-{gamma} and CD8+ T Cells Restore Host Defenses Against Pneumocystis carinii in Mice Depleted of CD4+ T Cells. J. Immunol. 162: 2890-2894 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»